Roche Chairman to step down in 2014
Roche’s long-standing Chairman of the Board of Directors, Franz B Humer, will not stand for re-election in 2014. Franz has been in the role as Chairman for approximately 16 years and announced his decision at the company’s recent Annual General Meeting.
“Roche is in excellent shape and well positioned to meet future challenges. This is a good time to hand over to a successor. I am looking forward to the next 12 months, and I intend to perform my duties as Chairman with enthusiasm and drive.”
Roche Chairman Franz B. Humer.
Roche will now nominate a successor for the chairmanship in autumn 2013. The Roche Board has decided that Franz Humer’s successor will also serve as non-executive Chairman, thus maintaining the established separation of the offices of Chairman and Chief Executive Officer.
This move follows the recent departure of Novartis’ Chairman, Daniel Vasella, and the outrage that pursued about his $78m payout.
Roche chairman to step down next year (Financial Times)
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.